We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Mylan NV | NASDAQ:MYL | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 15.855 | 15.71 | 15.90 | 0 | 01:00:00 |
NEW YORK, Aug. 14, 2015 /PRNewswire/ -- On behalf of funds that it manages, Paulson & Co. today voted all of its 21.9 million Mylan (NASDAQ: MYL) shares in support of the proposed merger with Perrigo (NYSE: PRGO).
John Paulson, President of Paulson & Co., said "The combination of Mylan's unparalleled generic capabilities with Perrigo's attractive OTC platform would create a global pharmaceutical powerhouse. The combined company will benefit from the growth in generics and OTC plus the migration of generics to OTC for many years to come. Mylan management has a successful track record of integrating acquisitions. The transaction is expected to be accretive based on cost synergies alone and likely meaningfully accretive when revenue synergies are taken into account."
Paulson & Co., founded in 1994 is an investment management firm specializing in event-driven strategies. Paulson has approximately US$20 billion in assets under management and has offices in New York, London and Hong Kong.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/paulson--co-votes-in-support-of-mylans-proposed-merger-with-perrigo-300128801.html
SOURCE Paulson & Co. Inc.
Copyright 2015 PR Newswire
1 Year Mylan NV Chart |
1 Month Mylan NV Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions